D. E. Shaw & Co., Inc. - PDS BIOTECHNOLOGY CORP ownership

PDS BIOTECHNOLOGY CORP's ticker is PDSB and the CUSIP is 70465T107. A total of 78 filers reported holding PDS BIOTECHNOLOGY CORP in Q3 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of PDS BIOTECHNOLOGY CORP
ValueSharesWeighting
Q1 2023$1,001,029
-77.7%
162,769
-52.1%
0.00%
-80.0%
Q4 2022$4,483,750
+10090.3%
339,678
+2179.1%
0.01%
Q3 2022$44,000
-91.4%
14,904
-82.1%
0.00%
Q1 2022$514,000
+114.2%
83,112
+180.7%
0.00%
Q4 2021$240,000
+2300.0%
29,605
+122.9%
0.00%
Q1 2020$10,000
-71.4%
13,2810.0%0.00%
Q4 2019$35,000
-23.9%
13,281
-2.9%
0.00%
Q3 2019$46,000
-43.9%
13,6780.0%0.00%
Q2 2019$82,000
-71.5%
13,678
-64.9%
0.00%
Q1 2019$288,00038,9340.00%
Other shareholders
PDS BIOTECHNOLOGY CORP shareholders Q3 2023
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 117,242$311,0000.07%
Andesa Financial Management Inc. 16,655$44,0000.04%
Sofinnova Investments, Inc. 142,635$378,0000.03%
INSPIRION WEALTH ADVISORS, LLC 22,875$61,0000.02%
REGENTATLANTIC CAPITAL LLC 15,753$42,0000.00%
Ellis Investment Partners, LLC 2,250$5,0000.00%
tru Independence LLC 500$00.00%
Renaissance Technologies 120,269$319,0000.00%
D. E. Shaw & Co., Inc. 13,281$35,0000.00%
VANGUARD GROUP INC 36,206$96,0000.00%
View complete list of PDS BIOTECHNOLOGY CORP shareholders